The Investigation of P1 gene in Mycoplasma pneumonia Isolated from atypic pneumonia by molecular methods, determine IgG antibody and MIC to ciprofloxacin antibiotic

Abstract Objective Mycoplasma pneumoniae, which causes atypical pneumonia, is a well-established pathogen of the respiratory tract. This bacteria is intrinsically susceptible to fluoroquinolones. But Recently, drug-resistant forms of this bacteria have been reported. This study aims to determine the prevalence of this bacteria by ELISA and PCR and MIC to ciprofloxacin. Methods The clinical samples (blood and nasopharyngeal swab) were collected from 100 patients who were referred to selective hospitals in Tehran with respiratory complaints were enrolled in 2017.Nasopharyngeal swab sample collections were cultured on PPLO broth and PPLO agar. After culturing and DNA extraction, PCR was performed by specific P1 genes primers. Ciprofloxacin's MIC of Mycoplasma pneumonia isolated was determined by Micro-broth dilution method. Also, measure serum IgG antibody titers were measured by ELISA Mycoplasma pneumonia. Results In this study, out of 100 samples 12, bacteria were isolated on PPLO agar.Using specific primers,7 samples of Mycoplasma speciesism-specific were positive for the presence of M.pneumoniae. 2 Ciprofloxacin resistant isolates were evaluated. ELISA results show that the IgG titre antibody In 19 samples is existent. Also,5 samples are intermediate. IgG antibody titre average in the whole sample is 27/66 U/ml but it is in Positive samples by P1 PCR is 45/75 U/ml. Conclusions This study showed that PCR is a sensitive and reliable method for rapid detection of M. pneumoniae bacteria in respiratory infectious samples.but the results of this method are different from the ELISA method. also, It seems that the Resistance to ciprofloxacin is relatively common among M. pneumoniae.